Triticum aestivum, commonly known as bread wheat, is an annual grass belonging to the Poaceae family. Wheatgrass is actually the grass of the wheat plant. Commercially wheatgrass can be found in the form of liquid or powder. Wheat is obviously used as food and wheat grass has many purported used. Wheatgrass contains chlorophyll, aminoacids, vitamins and various enzymes. Wheatgrass has been scientifically proposed with unique therapeutic potentials It can be found as a fresh product, tablets, frozen juice, or powder.
Recently, wheatgrass juice has been reported to be beneficial in ulcerative colitis in a clinical study and in favored by a lot of practitioners for the same purpose. Although, study included a small clinical set, it substantiated the use of wheatgrass in ulcerative colitis as is believed for a number of years. Wheatgrass has also been consumed as raw, powdered, juiced, or in culinary for centuries as nutrient rich food and as a detoxifier.
The use of wheat grass juice for therapeutic purposes was developed and popularized by Dr. Ann Wigmore. Although proponents of wheat grass juice have recommended it for decades as a treatment for various ailments, including chronic inflammatory conditions and malignancies, to date a very few small clinical trials exist.
The therapeutic qualities of wheat grass powder/juice have been attributed to its rich nutritional content—chlorophyll, vitamins (A, C and E), bio-flavenoids, minerals (iron, calcium and magnesium), and 17 amino acids, 8 of which are essential. Several studies have assessed an anti-mutagenic activity of wheat grass juice. Two of the studies have demonstrated an anti-mutagenic activity of wheat grass extract and attributed it to chlorophyll or to the flavonoids, particularly apigenin. Regardless, these studies need further investigation via clinical trials. Proponents of wheat grass also believe that the chlorophyll present in the leaves increases hemoglobin content in the blood. It is also thought that the enzymes present in wheat grass help to rid the body of toxins and carcinogens. However, none of these claims is backed by scientific studies.
Animal models suggest that wheat grass is useful in, increasing heamoglobin and hence the energy, skin problems, high cholesterol/lipid, antioxidant effects, ulcerative colitis, decreasing myelotoxicity in breast cancer patients undergoing chemotherapy, and reducing serum ferritin in patients with myelodysplastic syndrome. Larger studies are needed to evaluate these findings.
The dose of wheatgrass depends on many factors such as individual age, health, condition, capacity to tolerate the taste of juice; however, the optimum dose is upto 3gm a day of powder of 100cc of juice a day.
Nausea has been reported following consumption of wheat grass juice primarily because of its taste as it is raw juice. However, it is not reported with consumption of powder or capsule with powder.
Juice is consumed raw and thus it has bad taste. Because it is consumed raw, microbial contamination is also a concern. However, powder is dry and hence not susceptible to rapid microbial growth, and it does not have that bad of a taste.
Inconnate’s wheatgrass powder is USDA organic, tested for microbial contaminants, and is encapsulated to prevent bad taste. Quality and true Herbal supplement is our mission and thus the attributes of our products including wheatgrass are;
No, according to studies Wheatgrass is not known to suppress appetite or general calorie intake.
There have been no reports of interactions; however, we do not recommend pregnant or nursing women to take wheatgrass. We also recommend to speak with your doctor about wheatgrass capsules for further information.
No direct reports of any interactions of wheatgrass with any of the drug.
No, studies have not suggested that. In fact a few studies have suggested that wheatgrass is beneficial in maintaining blood pressure and blood sugar.
No, our product is caffeine free.
A randomized, double-blind, placebo controlled study 23 patients diagnosed clinically and sigmoidoscopically with active distal ulcerative colitis (UC) were randomly allocated to receive either 100 cc of wheat grass juice, or a matching placebo, daily for 1 month. Efficacy of treatment was assessed by a 4-fold disease activity index that included rectal bleeding and number of bowel movements as determined from patient records, a sigmoidoscopic evaluation, and global assessment by a physician. 21 patients completed the 1-month trial and 19 were evaluated with a second sigmoidoscopy within 3 days after completion of the study. Significant differences in improvements in rectal bleeding (P = 0.025), abdominal pain (P = 0.019), the disease activity index (DAI) score (P = 0.031), the physician global assessment (PGA) score (P = 0.031), and patients’ retrospective evaluation (P = 0.0053) were demonstrated in the treatment versus the placebo groups. No significant differences were found in the number of bowel movements or sense of abdominal bloating between the two groups. In the treatment group, 7 of the 9 patients (78%) had improved on the sigmoidoscopic evaluation, compared to the placebo group (3 of the 10 patients (30%)). To confirm the blindness at the end of the study patients were asked questions at the end of the study. In the treatment group, 6 of 11 patients believed they were getting wheat grass juice, and attributed it to their improved well-being, while in the placebo group, 7 out of 12 patients did not give a definite answer, 2 believed they were getting wheat grass, and 3 believed they were taking placebo. Nausea was found to be the most adverse effect (33%). A prominent positive side effect was increased vitality (41%). No side effects were reported in the placebo group.
E. Ben-Arye, E. Goldin, D. Wengrower, A. Stamper, R. Kohn & E. Berry; Wheat Grass Juice in the Treatment of Active Distal Ulcerative Colitis A Randomized Double-blind Placebo-controlled Trial . Scand J Gastroenterol 2002, 444-449.
Lai CN. Chlorophyll : The active factor in wheat sprout extract inhibiting the metabolic activation of carcinogen s in vitro. Nutrition Cancer 1979;1:19–21.